Influence of SARS-CoV-2 on Adult Human Neurogenesis.
Tomasz StępieńSylwia TarkaNatalia ChmuraMichał GrzegorczykAlbert AcewiczPaulina FelczakTeresa Wierzba-BobrowiczPublished in: Cells (2023)
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with the onset of neurological and psychiatric symptoms during and after the acute phase of illness. Inflammation and hypoxia induced by SARS-CoV-2 affect brain regions essential for fine motor function, learning, memory, and emotional responses. The mechanisms of these central nervous system symptoms remain largely unknown. While looking for the causes of neurological deficits, we conducted a study on how SARS-CoV-2 affects neurogenesis. In this study, we compared a control group with a group of patients diagnosed with COVID-19. Analysis of the expression of neurogenesis markers showed a decrease in the density of neuronal progenitor cells and newborn neurons in the SARS-CoV-2 group. Analysis of COVID-19 patients revealed increased microglial activation compared with the control group. The unfavorable effect of the inflammatory process in the brain associated with COVID-19 disease increases the concentration of cytokines that negatively affect adult human neurogenesis.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- cerebral ischemia
- endothelial cells
- subarachnoid hemorrhage
- neural stem cells
- oxidative stress
- brain injury
- ejection fraction
- blood brain barrier
- white matter
- mental health
- newly diagnosed
- air pollution
- prognostic factors
- induced pluripotent stem cells
- pluripotent stem cells
- traumatic brain injury
- spinal cord
- working memory
- spinal cord injury
- lps induced
- multiple sclerosis
- cerebrospinal fluid
- patient reported